NASHNEXT
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

NASHNEXT Trademark

Serial Number: 90538342

NASHNEXT is a trademark filed by LABORATORY CORPORATION OF AMERICAHOLDINGS on February 22, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

LABORATORY CORPORATION OF AMERICAHOLDINGS

531 SOUTH SPRING STREET
BURLINGTON, NC 27215

Entity Type: 03

Trademark Details

Filing Date

February 22, 2021

Registration Date

Not Registered

Published for Opposition

July 27, 2021

Goods & Services

DOWNLOADABLE SOFTWARE FOR DIAGNOSIS OF METABOLIC DISORDERS AND LIVER DISEASES AND IN PERMITTING THE TRANSMISSION AND EXCHANGE OF BIOLOGICAL DATA; SCIENTIFIC APPARATUS AND INSTRUMENTS, namely, SEQUENCERS, GENETIC ANALYZER MACHINES, BIOCHIPS FOR RECORDING, TREATING, REPRODUCING, TRANSMITTING DATA, IN THE FIELD OF CLINICAL RESEARCH AND DIAGNOSTICS OF METABOLIC DISORDERS AND LIVER DISEASES FOR USE IN GENETIC AND ENZYMATIC RESEARCH

PHARMACEUTICAL PREPARATIONS FOR THE PREVENTION, DIAGNOSIS, MONITORING AND IMAGING OF METABOLIC DISORDERS AND LIVER DISEASES; DIAGNOSTIC PREPARATIONS AND DIAGNOSTIC BIOMARKER REAGENTS FOR MEDICAL PURPOSES; DIAGNOSTIC TESTS FOR MEDICAL USE, namely, REAGENTS, NUCLEOTIDE SEQUENCES, ENZYMES, NUCLEOTIDES FOR BLOOD TESTING, REAGENTS KIT, CHEMICAL PRODUCT, BIOMARKING AGENTS, BLOOD AND BLOOD DERIVED SAMPLES, namely, PLASMA, SERUM, PLATELET FREE SAMPLES

DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC USE; CHEMICAL REAGENTS FOR INDUSTRIAL USE, OTHER THAN FOR MEDICAL OR VETERINARY PURPOSE; CHEMICAL REAGENTS FOR SCIENTIFIC RESEARCH PURPOSES

MEDICAL ANALYSIS SERVICES FOR THE DIAGNOSIS OF LIVER DISEASES, METABOLIC DISEASES, GASTROENTEROLOGICAL DISEASES, INFLAMMATORY DISEASES, IMMUNE DISEASES AND CANCERS; BLOOD SAMPLE ANALYSIS SERVICES; MEDICAL ASSISTANCE SERVICES; MEDICAL INFORMATION IN THE FIELD OF METABOLIC DISORDERS AND LIVER DISEASES

MEDICAL APPARATUSES FOR MEASURING METABOLIC DISORDERS AND LIVER DISEASES, NON-INVASIVE DIAGNOSTIC APPARATUS AND INSTRUMENTS FOR DETECTING METABOLIC DISORDERS AND LIVER DISEASES; MEDICAL DIAGNOSTIC APPARATUS, namely, MEDICAL DEVICES FOR DIAGNOSIS OF METABOLIC DISORDERS AND LIVER DISEASES, BLOOD ANALYSIS APPARATUS, DNA AND RNA ANALYSIS APPARATUS, GENE ANALYZER, MEDICAL DEVICES FOR MEASURING THE EVALUATION OF METABOLIC DISORDERS AND LIVER DISEASES, AND BLOOD ANALYSIS TOOLS FOR EVALUATION OF METABOLIC DISORDERS AND LIVER DISEASES

BIOLOGICAL RESEARCH; CLINICAL MEDICAL RESEARCH; COMPUTER PROGRAMMING; COMPUTER SOFTWARE DESIGN FOR OTHERS; LABORATORY RESEARCH SERVICES RELATING TO PHARMACEUTICALS IN THE FIELD OF METABOLIC DISORDERS AND LIVER DISEASES; INDUSTRIAL RESEARCH SERVICES IN THE FIELD OF PHARMACEUTICALS

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Mar 22, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Mar 22, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2021 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 8, 2021 ZZZX
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Aug 25, 2021 JURT
LETTER OF PROTEST EVIDENCE FORWARDED
Aug 25, 2021 LOPT
EXTENSION OF TIME TO OPPOSE RECEIVED
Aug 13, 2021 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 27, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 27, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 7, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 2021 CNSA
ASSIGNED TO EXAMINER
Jun 21, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2021 NWOS
NEW APPLICATION ENTERED
Feb 25, 2021 NWAP